Colgate-Palmolive Company (CL)
| Market Cap | 63.15B |
| Revenue (ttm) | 20.10B |
| Net Income (ttm) | 2.91B |
| Shares Out | 806.06M |
| EPS (ttm) | 3.57 |
| PE Ratio | 21.94 |
| Forward PE | 20.77 |
| Dividend | $2.08 (2.66%) |
| Ex-Dividend Date | Jan 21, 2026 |
| Volume | 5,239,576 |
| Open | 77.67 |
| Previous Close | 77.25 |
| Day's Range | 77.15 - 78.48 |
| 52-Week Range | 74.55 - 100.18 |
| Beta | 0.29 |
| Analysts | Buy |
| Price Target | 90.40 (+15.39%) |
| Earnings Date | Jan 30, 2026 |
About CL
Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items. This segment markets and sells i... [Read more]
Financial Performance
In 2024, Colgate-Palmolive Company's revenue was $20.10 billion, an increase of 3.31% compared to the previous year's $19.46 billion. Earnings were $2.89 billion, an increase of 25.61%.
Financial StatementsAnalyst Summary
According to 16 analysts, the average rating for CL stock is "Buy." The 12-month stock price target is $90.4, which is an increase of 15.39% from the latest price.
News
Colgate-Palmolive Stock Should Do Better in 2026, but That's Not Saying Much
With consumer staples stocks out of favor, Colgate-Palmolive's share price slumped in 2025. The company has accelerated its product development pace.
Colgate Declares Regular Quarterly Dividend
NEW YORK--(BUSINESS WIRE)--The Board of Directors of Colgate-Palmolive Company (NYSE:CL) today declared a quarterly cash dividend of $0.52 per common share, payable on February 13, 2026, to shareholde...
Colgate-Palmolive Company (CL) Presents at Morgan Stanley Global Consumer & Retail Conference 2025 Transcript
Colgate-Palmolive Company (CL) Presents at Morgan Stanley Global Consumer & Retail Conference 2025 Transcript
Colgate-Palmolive: Wide Moat And A Mispriced Future
Colgate-Palmolive (CL)'s diverse category system creates a deeper moat than its simple products suggest. It shows how shared chemistry, manufacturing flexibility and retail presence strengthen its com...
5 Top Dividend Stocks to Buy in November
For investors, it's generally wise to buy and hold companies that continually raise their dividends. There are deals in energy, healthcare, consumer staples, and even the tech space.
Colgate-Palmolive: This Dividend King Is Rebounding (Technical Analysis)
Colgate-Palmolive (CL) is a Dividend King with a 62-year record of dividend growth and global dominance in oral care products. CL recently rebounded from a multi-year earnings decline, driven by its 2...
Don't Give Up on Dividend Stocks. 5 Dividend Kings Down Between 5% and 33% to Buy in November
The decline in consumer staples stocks shows the disconnect between the consumer economy and stock market performance. Dividend Kings are excellent choices for investors who prioritize dividend reliab...
Colgate-Palmolive Webcasts Fireside Chat at the Morgan Stanley Global Consumer & Retail Conference
NEW YORK--(BUSINESS WIRE)--Colgate-Palmolive (NYSE:CL) Chief Growth Officer, John Hazlin and Chief Financial Officer, Stan Sutula, will participate in a fireside chat at the Morgan Stanley Global Cons...
Down 15% Year to Date, Is This Dividend King a Buy?
Colgate has been a solid defensive stock, rising 352% since 2000 while boosting its dividend. Despite this, it has narrowly trailed the S&P 500's return over that time frame.
3 Dividend Stocks Down 11%, 29%, and 41% to Buy in November
AbbVie continues to enjoy strong growth from its new blockbuster drugs, Rinvoq and Skyrizi. Colgate-Palmolive is a rock-solid dividend growth stock simply out of fashion amid the tech craze.
Colgate-Palmolive Analysts Cut Their Forecasts After Q3 Earnings
Colgate-Palmolive Company (NYSE:CL) reported downbeat third-quarter earnings on Friday.
Best Dividend Aristocrats For November 2025
The ProShares S&P 500 Dividend Aristocrats ETF (NOBL) has underperformed SPY in 2025, with a 6.27% YTD gain versus SPY's 17.8%. Despite overall underperformance, select Aristocrats like CAT, CAH, CHRW...
Colgate-Palmolive Company (CL) Q3 2025 Earnings Call Transcript
Colgate-Palmolive Company ( CL) Q3 2025 Earnings Call October 31, 2025 8:30 AM EDT Company Participants John Faucher - Chief Investor Relations Officer and Executive VP of M&A Noel Wallace - Chairman...
Colgate-Palmolive posts higher Q3 sales as pricing gains offset volume decline
Colgate-Palmolive Co. reported slightly higher third-quarter sales on Friday, as increased pricing helped offset a drop in product volumes. The New York-based consumer products company, which makes Co...
Colgate-Palmolive cuts annual sales forecast on signs of sluggish demand
Toothpaste maker Colgate-Palmolive cut its annual sales forecast on Friday, in a sign that rising economic uncertainty is squeezing consumer appetite to spend on higher-priced items even in essential ...
Colgate-Palmolive Sales Rise as Higher Prices Offset Lower Volumes
Colgate-Palmolive said sales rose in the third quarter, as higher prices offset a decline in volumes.
Colgate-Palmolive Company Announces 3rd Quarter 2025 Results
NEW YORK--(BUSINESS WIRE)--Colgate-Palmolive Company (NYSE:CL): Net sales increased 2.0%; Organic sales* increased 0.4%, including a 0.8% negative impact from lower private label pet sales having exit...
Colgate-Palmolive Earnings Are Imminent; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call
Colgate-Palmolive Company (NYSE:CL) will release earnings results for the third quarter, before the opening bell on Friday, Oct. 31.
Best Dividend Kings: October 2025
Dividend Kings are underperforming SPY in 2025, with a year-to-date return gap of 13.10%, but 12 Kings remain ahead of the index. Top performers include NFG, JNJ, ABBV, MO, FTS, ADM, NUE, GRC, NWN, PH...
Colgate-Palmolive: 2 Reasons Why The Share Price Drop Has Gone Too Far (Upgrade)
Colgate-Palmolive stock has fallen by nearly 20% over the past year, and this is raising questions regarding market expectations. It seems that the market is pricing in an adverse scenario for margins...
5 Stocks That Could Create Lasting Generational Wealth
Consumer spending is the driving force of America's economy. E-commerce, streaming, public safety, and household products are winning investment themes.
Colgate-Palmolive Webcasts 2025 Third Quarter Earnings Conference Call October 31, 2025 – 8:30 a.m. ET
NEW YORK--(BUSINESS WIRE)--Colgate-Palmolive Company (NYSE:CL) will provide a live webcast of its 2025 third quarter earnings conference call on Friday, October 31, 2025, at 8:30 a.m. ET. The call wil...
3 High-Yield Dividend King Stocks Down Between 9% and 14% to Buy in October
The S&P 500 (^GSPC 0.53%) is having a great year, led by strong gains in tech, communications, financials, and industrials. But not every sector is performing well.
Oversold Conditions For Colgate-Palmolive
Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a tec...
